These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3776935)

  • 1. Long-term bromocriptine treatment for prolactin-secreting macroadenoma.
    Huseman CA; Rizk G; Hahn F
    Am J Dis Child; 1986 Dec; 140(12):1216-7. PubMed ID: 3776935
    [No Abstract]   [Full Text] [Related]  

  • 2. Normal growth and pubertal development during bromocriptine treatment for a prolactin-secreting pituitary macroadenoma.
    Dalzell GW; Atkinson AB; Carson DJ; Sheridan B
    Clin Endocrinol (Oxf); 1987 Feb; 26(2):169-72. PubMed ID: 3665115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enlargement of a prolactin-secreting pituitary microadenoma during bromocriptine treatment. Case report.
    Crosignani PG; Mattei A; Ferrari C; Giovanelli MA
    Br J Obstet Gynaecol; 1982 Feb; 89(2):169-70. PubMed ID: 7066250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of ejaculatory incompetence with bromocriptine in a man with prolactin-secreting pituitary tumor.
    Oseko F; Taniguchi A; Kono T; Imura H; Komatsu Y
    J Urol; 1983 Apr; 129(4):835-6. PubMed ID: 6842715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromocriptine treatment of prolactin-secreting tumors: surgical implications.
    Weiss MH; Wycoff RR; Yadley R; Gott P; Feldon S
    Neurosurgery; 1983 Jun; 12(6):640-2. PubMed ID: 6877546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid shrinkage of a prolactin-secreting pituitary tumor with bromocriptine: CT documentation.
    Chernow B; Buck DR; Early CB; Ray J; O'Brian JT
    AJNR Am J Neuroradiol; 1982; 3(4):442-3. PubMed ID: 6810677
    [No Abstract]   [Full Text] [Related]  

  • 7. Bromocriptine-unresponsive prolactin macroadenoma in a prepubertal female.
    Cheyne KL; Lightner ES; Comerci GD
    J Adolesc Health Care; 1988 Jul; 9(4):331-4. PubMed ID: 3417510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bromocriptine reduces the size of cells in prolactin-secreting pituitary adenomas.
    Landolt AM; Minder H; Osterwalder V; Landolt TA
    Experientia; 1983 Jun; 39(6):625-6. PubMed ID: 6852202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of a prolactin-secreting pituitary tumor during long-term treatment with bromocriptine.
    Nillius SJ; Bergh T; Lundberg PO; Stahle J; Wide L
    Fertil Steril; 1978 Dec; 30(6):710-2. PubMed ID: 729834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bromocriptine treatment of prolactin-secreting pituitary adenomas may restore pituitary function.
    Warfield A; Finkel DM; Schatz NJ; Savino PJ; Snyder PJ
    Ann Intern Med; 1984 Dec; 101(6):783-5. PubMed ID: 6497193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persisting suppression of prolactin secretion after long-term treatment with bromocriptine in patients with prolactinomas.
    Eversmann T; Fahlbusch R; Rjosk HK; von Werder K
    Acta Endocrinol (Copenh); 1979 Nov; 92(3):413-27. PubMed ID: 574700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long term suppression of prolactin concentrations after bromocriptine induced regression of pituitary prolactinomas.
    Hancock KW; Scott JS; Lamb JT; Gibson RM; Chapman C
    Br Med J (Clin Res Ed); 1985 Jan; 290(6462):117-8. PubMed ID: 3917709
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolactinoma during pregnancy causing compression symptoms responding to bromocriptine therapy.
    Saunders NJ
    Postgrad Med J; 1985 Sep; 61(719):829-30. PubMed ID: 4059146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does bromocriptine have a cytocidal effect on prolactinoma cells? Report of a case.
    Gen M; Uozumi T; Shinohara S; Naito M; Ito A; Mori S; Kajiwara H
    Neurol Med Chir (Tokyo); 1983 Jan; 23(1):61-5. PubMed ID: 6188984
    [No Abstract]   [Full Text] [Related]  

  • 15. Invasive mixed growth hormone/prolactin secreting pituitary tumour: complete shrinking by octreotide and bromocriptine, and lack of tumour growth relapse 20 months after octreotide withdrawal.
    Sadoul JL; Thyss A; Freychet P
    Acta Endocrinol (Copenh); 1992 Feb; 126(2):179-83. PubMed ID: 1543025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin secreting pituitary carcinoma.
    Petterson T; MacFarlane IA; MacKenzie JM; Shaw MD
    J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1205-6. PubMed ID: 1479402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of pituitary-tumour size in patients with prolactinomas and acromegaly treated with bromocriptine with or without radiotherapy.
    Wass JA; Moult PJ; Thorner MO; Dacie JE; Charlesworth M; Jones AE; Besser GM
    Lancet; 1979 Jul; 2(8133):66-9. PubMed ID: 87966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of bromocriptine on DNA synthesis, growth and hormone secretion of spontaneous pituitary tumours in the rat.
    Prysor-Jones RA; Jenkins JS
    J Endocrinol; 1981 Mar; 88(3):463-9. PubMed ID: 7217831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperprolactinemic response after bromocriptine withdrawal in women with prolactin-secreting pituitary tumors.
    Maxson WS; Dudzinski M; Handwerger SH; Hammond CB
    Fertil Steril; 1984 Feb; 41(2):218-23. PubMed ID: 6698215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the elution pattern of the serum and CSF prolactin fractionated by gel filtration chromatography in cases of bromocriptine-resistant prolactinoma].
    Sakamoto T; Kowada M; Hasegawa H; Ishino Y; Mineura K; Wakisaka A; Fukushima M
    Neurol Med Chir (Tokyo); 1987 Mar; 27(3):195-201. PubMed ID: 2442642
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.